3/3
10:31 am
ptct
Investment Manager Bets Big on PTCT Stock, Adds 41,000 Shares, According to Recent SEC Filing [Yahoo! Finance]
Low
Report
Investment Manager Bets Big on PTCT Stock, Adds 41,000 Shares, According to Recent SEC Filing [Yahoo! Finance]
2/27
04:09 am
ptct
Global Ferroptosis Targeting Therapy Market Opportunity Report 2026: Therapeutic Approaches, Technology Development Platforms & Clinical Trials Insights By Company, Country, Indication & Phase [Yahoo! Finance]
Low
Report
Global Ferroptosis Targeting Therapy Market Opportunity Report 2026: Therapeutic Approaches, Technology Development Platforms & Clinical Trials Insights By Company, Country, Indication & Phase [Yahoo! Finance]
2/23
08:29 am
ptct
PTC Therapeutics to Participate at Upcoming Investor Conferences [Yahoo! Finance]
Low
Report
PTC Therapeutics to Participate at Upcoming Investor Conferences [Yahoo! Finance]
2/23
08:03 am
ptct
PTC Therapeutics (NASDAQ:PTCT) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
Low
Report
PTC Therapeutics (NASDAQ:PTCT) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
2/23
08:00 am
ptct
PTC Therapeutics to Participate at Upcoming Investor Conferences
Low
Report
PTC Therapeutics to Participate at Upcoming Investor Conferences
2/23
07:01 am
ptct
PTC Therapeutics (NASDAQ:PTCT) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
Low
Report
PTC Therapeutics (NASDAQ:PTCT) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
2/23
01:30 am
ptct
How Sephience Is Reshaping The Story For PTC Therapeutics (PTCT) And Analyst Expectations [Yahoo! Finance]
Low
Report
How Sephience Is Reshaping The Story For PTC Therapeutics (PTCT) And Analyst Expectations [Yahoo! Finance]
2/20
07:12 pm
ptct
PTC Therapeutics (PTCT) Reports Q4 Loss, Misses Revenue Estimates [Yahoo! Finance]
Low
Report
PTC Therapeutics (PTCT) Reports Q4 Loss, Misses Revenue Estimates [Yahoo! Finance]
2/20
03:14 pm
ptct
PTC Therapeutics (NASDAQ:PTCT) had its "overweight" rating reaffirmed by analysts at Cantor Fitzgerald.
Low
Report
PTC Therapeutics (NASDAQ:PTCT) had its "overweight" rating reaffirmed by analysts at Cantor Fitzgerald.
2/20
01:32 pm
ptct
PTC Therapeutics, Inc. (PTCT) Q4 2025 Earnings Call Transcript [Seeking Alpha]
Low
Report
PTC Therapeutics, Inc. (PTCT) Q4 2025 Earnings Call Transcript [Seeking Alpha]
2/20
09:03 am
ptct
PTC Therapeutics (NASDAQ:PTCT) had its "sector perform" rating reaffirmed by analysts at Royal Bank Of Canada.
Low
Report
PTC Therapeutics (NASDAQ:PTCT) had its "sector perform" rating reaffirmed by analysts at Royal Bank Of Canada.
2/20
08:03 am
ptct
PTC Therapeutics (NASDAQ:PTCT) had its price target lowered by analysts at Bank of America Corporation from $97.00 to $93.00. They now have a "buy" rating on the stock.
Low
Report
PTC Therapeutics (NASDAQ:PTCT) had its price target lowered by analysts at Bank of America Corporation from $97.00 to $93.00. They now have a "buy" rating on the stock.
2/20
08:02 am
ptct
PTC Therapeutics (NASDAQ:PTCT) was given a new $86.00 price target on by analysts at Wells Fargo & Company.
Medium
Report
PTC Therapeutics (NASDAQ:PTCT) was given a new $86.00 price target on by analysts at Wells Fargo & Company.
2/20
12:16 am
ptct
PTC Therapeutics Inc (PTCT) Q4 2025 Earnings Call Highlights: Surpassing Revenue Expectations ... [Yahoo! Finance]
Medium
Report
PTC Therapeutics Inc (PTCT) Q4 2025 Earnings Call Highlights: Surpassing Revenue Expectations ... [Yahoo! Finance]
2/19
06:03 pm
ptct
PTC Therapeutics: Q4 Earnings Snapshot [Yahoo! Finance]
Medium
Report
PTC Therapeutics: Q4 Earnings Snapshot [Yahoo! Finance]
2/19
05:28 pm
ptct
PTC Therapeutics stock down over 2% on worse-than-expected Q4 results, guidance [Yahoo! Finance]
Medium
Report
PTC Therapeutics stock down over 2% on worse-than-expected Q4 results, guidance [Yahoo! Finance]
2/19
04:01 pm
ptct
PTC Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2025 Financial Results
Medium
Report
PTC Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2025 Financial Results
2/12
05:00 pm
ptct
PTC Therapeutics Provides Regulatory Update on Translarna™
Low
Report
PTC Therapeutics Provides Regulatory Update on Translarna™
2/5
08:46 am
ptct
PTC Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, Feb. 19, 2026 [Yahoo! Finance]
Low
Report
PTC Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, Feb. 19, 2026 [Yahoo! Finance]
2/5
08:00 am
ptct
PTC Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, Feb. 19, 2026
Low
Report
PTC Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, Feb. 19, 2026
1/29
10:59 am
ptct
PTC Therapeutics (NASDAQ:PTCT) had its "hold" rating reaffirmed by analysts at TD Cowen.
Low
Report
PTC Therapeutics (NASDAQ:PTCT) had its "hold" rating reaffirmed by analysts at TD Cowen.
1/27
06:00 pm
ptct
PTC Therapeutics (NASDAQ:PTCT) was upgraded by analysts at Barclays PLC from an "equal weight" rating to an "overweight" rating.
Low
Report
PTC Therapeutics (NASDAQ:PTCT) was upgraded by analysts at Barclays PLC from an "equal weight" rating to an "overweight" rating.
1/12
08:51 am
ptct
PTC Therapeutics Provides Update at J.P. Morgan Annual Healthcare Conference [Yahoo! Finance]
Low
Report
PTC Therapeutics Provides Update at J.P. Morgan Annual Healthcare Conference [Yahoo! Finance]
1/12
08:30 am
ptct
PTC Therapeutics Provides Update at J.P. Morgan Annual Healthcare Conference
Low
Report
PTC Therapeutics Provides Update at J.P. Morgan Annual Healthcare Conference
1/8
04:30 pm
ptct
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)